Last updated: February 20, 2026
Rubidium chloride (Rb-82) is a radioisotope used in positron emission tomography (PET) imaging, primarily for myocardial perfusion scans. Rb-82 is produced from a Strontium-82/Rubidium-82 generator system, making the supply chain dependent on specific manufacturers providing generators or the isotope itself.
Key Suppliers of Rb-82 Generators and Isotope
1. CardioGen-82 (Bracco Diagnostics Inc.)
- Product: CardioGen-82 generator using Strontium-82.
- Availability: The sole FDA-approved generator in the United States.
- Supply Chain: Licensed to provide Rb-82 generators domestically.
- Status: Approved for medical use since 2014.
2. Eckert & Ziegler
- Product: Strontium-82 generators for Rb-82 production.
- Markets: Provides generators primarily for European markets.
- Status: Certified under European regulations (CE mark).
3. Isotope Production Companies
- Companies like Nordion and Isotope Technologies GERMANY manufacture and supply Sr-82 sources that can be used to produce Rb-82 generators.
- Generally, these firms focus on supplying the raw isotope, which is then used by licensed generator manufacturers.
4. Other Regional Suppliers
- Several regional nuclear medicine radiopharmacies and isotope suppliers provide Rb-82 directly or via distributor channels, mostly in North America and Europe.
- These include smaller companies and academic institutions licensed to produce Rb-82 under regulatory standards.
Supply Chain Considerations
| Aspect |
Details |
| Production Volume |
Limited by the half-life of Sr-82 (25 days), constraining stockpiles. |
| Regulatory Approval |
Generators must comply with regional health authority standards (FDA, EMA, etc.). |
| Geographic Reach |
Supply primarily in North America (Bracco), Europe (Eckert & Ziegler), and Asia (regional suppliers). |
| Pricing |
Rb-82 generator costs range from $60,000 to $100,000 per unit, with annual service fees. |
Market Dynamics
- The small number of suppliers leads to limited competition, affecting prices and supply flexibility.
- The expiration of Sr-82 isotope production licenses in some regions could reduce the availability of raw material.
- Manufacturers focus on maintaining generator nanofabrication to prevent supply disruptions due to short half-life.
Major Regulatory and Policy Frameworks
| Region |
Regulatory Agency |
Impact |
| United States |
FDA |
Approves Rb-82 generator devices, sets safety standards. |
| European Union |
European Medicines Agency |
Approves and regulates radiopharmaceuticals, including Sr-82 generators. |
| Japan |
Pharmaceuticals and Medical Devices Agency (PMDA) |
Regulates manufacturing and distribution of Rb-82 products. |
Strategic Implications for Procurement
- Relying on a single manufacturer like Bracco for U.S. supply introduces geopolitical, regulatory, and economic risks.
- Diversification of suppliers is challenging due to regulatory barriers and limited raw isotope availability.
- Manufacturers and healthcare providers need proactive inventory management due to the isotope’s short half-life and production constraints.
Key Takeaways
- Bracco Diagnostics is the sole FDA-approved supplier of Rb-82 generators in the U.S.
- EU markets rely on Eckert & Ziegler and regional companies.
- The supply chain depends on Sr-82 isotope production, which is limited by half-life and manufacturing licenses.
- Prices range between $60,000 and $100,000 per generator, with ongoing service costs.
- Supply disruptions are possible due to regulatory or production issues relating to Sr-82.
Frequently Asked Questions
1. Are there alternatives to Rb-82 for PET myocardial perfusion imaging?
Yes, options include N-13 ammonia and O-15 water, but Rb-82 is often preferred for its quick imaging times and high spatial resolution.
2. How does the short half-life of Sr-82 affect supply stability?
It limits stockpiling, requiring continuous on-demand production and reliable transportation within regional networks.
3. What is the typical cost of Rb-82 generators?
Initial acquisition costs range from $60,000 to $100,000, with annual service fees.
4. Can Rb-82 generators be reused?
Yes, but they have a finite lifespan, typically around one year or after a specific number of elutions.
5. Are there upcoming innovations to improve Rb-82 supply?
Research includes developing longer-lived isotopes or alternative production methods, but none are commercially available yet.
References
[1] U.S. Food and Drug Administration (FDA). (2014). CardioGen-82 Device Approval.
[2] Eckert & Ziegler. (2022). European Market and Product Portfolio.
[3] ICRP. (2018). Report on Medical Radioisotope Supply Chains.
[4] World Nuclear Association. (2022). Uranium and Related Facilities.
[5] Society of Nuclear Medicine and Molecular Imaging. (2020). PET Radiopharmaceuticals: Supply Chain Overview.
